Diseases [C] » Digestive System Diseases [C06] » Gastrointestinal Diseases
Description
Diseases in any segment of the GASTROINTESTINAL TRACT from ESOPHAGUS to RECTUM. MeSH
Hierarchy View
Subtype Terms (9)
Esophageal Diseases
53 drugs (32 approved, 21 experimental)
Gastroenteritis
57 drugs (21 approved, 36 experimental)
Gastrointestinal Hemorrhage
28 drugs (23 approved, 5 experimental)
Gastrointestinal Neoplasms
148 drugs (81 approved, 67 experimental)
Intestinal Diseases
116 drugs (73 approved, 43 experimental)
Rumination Syndrome
1 approved drug
Stomach Diseases
95 drugs (66 approved, 29 experimental)
Phase 4 Indicated Drugs (14)
Other Experimental Indicated Drugs (42)
Organization Involved with Phase 3 Indications (42)
Organization Involved with Phase 2 Indications (51)
National Center for Research Resources (NCRR)
Nordmark Arzneimittel GmbH & Co. KG
People's Liberation Army of China
Organization Involved with Phase 1 Indications (18)
Organization Involved with Other Experimental Indications (42)
Bogomolets National Medical University
Carle Health Care Incorporated
Jiangxi Hospital of Traditional Chinese Medicine
Jiangxi Provincial Cancer Hospital
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.